Global Antidiabetics Drug Industry Research Report 2020, Forecast to 2025

September 2020 | 109 pages | ID: G4A3311F2C1FEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Antidiabetics Drug market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Antidiabetics Drug is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Antidiabetics Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Antidiabetics Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Antidiabetics Drug market are discussed.

The market is segmented by types:

• Metformin (Biguanides)
• Insulin Sensitization Agent (TZD Use)
• Sulfonated Ideal Urea Class
• Meglitinides
• Alpha Glucosidase Inhibitors

It can be also divided by applications:

• Hospital
• Household

And this report covers the historical situation, present status and the future prospects of the global Antidiabetics Drug market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• AstraZeneca
• Novo Nordisk
• Eli-Lilly
• Bayer
• Novartis
• Boehringer Ingelheim
• Merck
• Johnson & Johnson
• Sanofi

Report Includes:

• xx data tables and xx additional tables
• An overview of global Antidiabetics Drug market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Antidiabetics Drug market
• Profiles of major players in the industry, including AstraZeneca, Novo Nordisk, Eli-Lilly, Bayer, Novartis.....

Research Objectives

• To study and analyze the global Antidiabetics Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Antidiabetics Drug market by identifying its various subsegments.
• Focuses on the key global Antidiabetics Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Antidiabetics Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Antidiabetics Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Antidiabetics Drug Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Antidiabetics Drug Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 ANTIDIABETICS DRUG INDUSTRY OVERVIEW

2.1 Global Antidiabetics Drug Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Antidiabetics Drug Global Import Market Analysis
  2.1.2 Antidiabetics Drug Global Export Market Analysis
  2.1.3 Antidiabetics Drug Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Metformin (Biguanides)
  2.2.2 Insulin Sensitization Agent (TZD Use)
  2.2.3 Sulfonated Ideal Urea Class
  2.2.4 Meglitinides
  2.2.5 Alpha Glucosidase Inhibitors
2.3 Market Analysis by Application
  2.3.1 Hospital
  2.3.2 Household
2.4 Global Antidiabetics Drug Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Antidiabetics Drug Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Antidiabetics Drug Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Antidiabetics Drug Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Antidiabetics Drug Manufacturer Market Share
  2.4.5 Top 10 Antidiabetics Drug Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Antidiabetics Drug Market
  2.4.7 Key Manufacturers Antidiabetics Drug Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Antidiabetics Drug Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Antidiabetics Drug Industry Impact
  2.7.1 How the Covid-19 is Affecting the Antidiabetics Drug Industry
  2.7.2 Antidiabetics Drug Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Antidiabetics Drug Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Antidiabetics Drug Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL ANTIDIABETICS DRUG MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Antidiabetics Drug Sales Market Share by Region
4.2 Global Antidiabetics Drug Revenue Market Share by Region (2015-2019)
4.3 Global Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Antidiabetics Drug Market Size Detail
  4.4.1 North America Antidiabetics Drug Sales Growth Rate (2015-2020)
  4.4.2 North America Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Antidiabetics Drug Market Size Detail
  4.5.1 Europe Antidiabetics Drug Sales Growth Rate (2015-2020)
  4.5.2 Europe Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Antidiabetics Drug Market Size Detail
  4.6.1 Japan Antidiabetics Drug Sales Growth Rate (2015-2020)
  4.6.2 Japan Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Antidiabetics Drug Market Size Detail
  4.7.1 China Antidiabetics Drug Sales Growth Rate (2015-2020)
  4.7.2 China Antidiabetics Drug Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL ANTIDIABETICS DRUG MARKET SEGMENT BY TYPE

5.1 Global Antidiabetics Drug Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Antidiabetics Drug Sales and Market Share by Type (2015-2020)
  5.1.2 Global Antidiabetics Drug Revenue and Market Share by Type (2015-2020)
5.2 Metformin (Biguanides) Sales Growth Rate and Price
  5.2.1 Global Metformin (Biguanides) Sales Growth Rate (2015-2020)
  5.2.2 Global Metformin (Biguanides) Price (2015-2020)
5.3 Insulin Sensitization Agent (TZD Use) Sales Growth Rate and Price
  5.3.1 Global Insulin Sensitization Agent (TZD Use) Sales Growth Rate (2015-2020)
  5.3.2 Global Insulin Sensitization Agent (TZD Use) Price (2015-2020)
5.4 Sulfonated Ideal Urea Class Sales Growth Rate and Price
  5.4.1 Global Sulfonated Ideal Urea Class Sales Growth Rate (2015-2020)
  5.4.2 Global Sulfonated Ideal Urea Class Price (2015-2020)
5.5 Meglitinides Sales Growth Rate and Price
  5.5.1 Global Meglitinides Sales Growth Rate (2015-2020)
  5.5.2 Global Meglitinides Price (2015-2020)
5.6 Alpha Glucosidase Inhibitors Sales Growth Rate and Price
  5.6.1 Global Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020)
  5.6.2 Global Alpha Glucosidase Inhibitors Price (2015-2020)

6 GLOBAL ANTIDIABETICS DRUG MARKET SEGMENT BY APPLICATION

6.1 Global Antidiabetics DrugSales Market Share by Application (2015-2020)
6.2 Hospital Sales Growth Rate (2015-2020)
6.3 Household Sales Growth Rate (2015-2020)

7 GLOBAL ANTIDIABETICS DRUG MARKET FORECAST

7.1 Global Antidiabetics Drug Sales, Revenue Forecast
  7.1.1 Global Antidiabetics Drug Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Antidiabetics Drug Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Antidiabetics Drug Price and Trend Forecast (2020-2025)
7.2 Global Antidiabetics Drug Sales Forecast by Region (2020-2025)
  7.2.1 North America Antidiabetics Drug Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Antidiabetics Drug Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Antidiabetics Drug Production, Revenue Forecast (2020-2025)
  7.2.4 China Antidiabetics Drug Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF ANTIDIABETICS DRUG INDUSTRY KEY MANUFACTURERS

8.1 AstraZeneca
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 AstraZeneca Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 AstraZeneca News
8.2 Novo Nordisk
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Novo Nordisk Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Novo Nordisk News
8.3 Eli-Lilly
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Eli-Lilly Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Eli-Lilly News
8.4 Bayer
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Bayer Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Bayer News
8.5 Novartis
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Novartis Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Novartis News
8.6 Boehringer Ingelheim
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Boehringer Ingelheim Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Boehringer Ingelheim News
8.7 Merck
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Merck Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Merck News
8.8 Johnson & Johnson
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 Johnson & Johnson Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 Johnson & Johnson News
8.9 Sanofi
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 Sanofi Antidiabetics Drug Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 Sanofi News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Antidiabetics Drug Picture
Figure Research Programs/Design for This Report
Figure Global Antidiabetics Drug Market by Regions (2019)
Table Global Market Antidiabetics Drug Comparison by Regions (M USD) 2019-2025
Table Global Antidiabetics Drug Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Antidiabetics Drug by Type in 2019
Figure Metformin (Biguanides) Picture
Figure Insulin Sensitization Agent (TZD Use) Picture
Figure Sulfonated Ideal Urea Class Picture
Figure Meglitinides Picture
Figure Alpha Glucosidase Inhibitors Picture
Table Global Antidiabetics Drug Sales by Application (2019-2025)
Figure Global Antidiabetics Drug Sales Market Share by Application in 2019
Figure Hospital Picture
Figure Household Picture
Table Global Antidiabetics Drug Sales by Manufacturer (2018-2020)
Figure Global Antidiabetics Drug Sales Market Share by Manufacturer in 2019
Table Global Antidiabetics Drug Revenue by Manufacturer (2018-2020)
Figure Global Antidiabetics Drug Revenue Market Share by Manufacturer in 2019
Table Global Antidiabetics Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Antidiabetics Drug Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Antidiabetics Drug Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Antidiabetics Drug Market
Table Key Manufacturers Antidiabetics Drug Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidiabetics Drug
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Antidiabetics Drug Sales (K Units) by Region (2015-2020)
Table Global Antidiabetics Drug Sales Market Share by Region (2015-2019)
Figure Global Antidiabetics Drug Sales Market Share by Region (2015-2019)
Figure Global Antidiabetics Drug Sales Market Share by Region in 2018
Table Global Antidiabetics Drug Revenue (Million US$) by Region (2015-2020)
Table Global Antidiabetics Drug Revenue Market Share by Region (2015-2020)
Figure Global Antidiabetics Drug Revenue Market Share by Region (2015-2020)
Figure Global Antidiabetics Drug Revenue Market Share by Region in 2019
Table Global Antidiabetics Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Antidiabetics Drug Sales (K Units) Growth Rate (2015-2020)
Table North America Antidiabetics Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Antidiabetics Drug Sales (K Units) Growth Rate (2015-2020)
Table Europe Antidiabetics Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Antidiabetics Drug Sales (K Units) Growth Rate (2015-2020)
Table Japan Antidiabetics Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Antidiabetics Drug Sales (K Units) Growth Rate (2015-2020)
Table China Antidiabetics Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Antidiabetics Drug Sales by Type (2015-2020)
Table Global Antidiabetics Drug Sales Market Share by Type (2015-2020)
Figure Global Antidiabetics Drug Sales Market Share by Type in 2019
Table Global Antidiabetics Drug Revenue by Type (2015-2020)
Table Global Antidiabetics Drug Revenue Market Share by Type (2015-2020)
Figure Global Antidiabetics Drug Revenue Market Share by Type in 2019
Figure Global Metformin (Biguanides) Sales Growth Rate (2015-2020)
Figure Global Metformin (Biguanides) Price (2015-2020)
Figure Global Insulin Sensitization Agent (TZD Use) Sales Growth Rate (2015-2020)
Figure Global Insulin Sensitization Agent (TZD Use) Price (2015-2020)
Figure Global Sulfonated Ideal Urea Class Sales Growth Rate (2015-2020)
Figure Global Sulfonated Ideal Urea Class Price (2015-2020)
Figure Global Meglitinides Sales Growth Rate (2015-2020)
Figure Global Meglitinides Price (2015-2020)
Figure Global Alpha Glucosidase Inhibitors Sales Growth Rate (2015-2020)
Figure Global Alpha Glucosidase Inhibitors Price (2015-2020)
Table Global Antidiabetics Drug Sales by Application (2015-2020)
Table Global Antidiabetics Drug Sales Market Share by Application (2015-2020)
Figure Global Antidiabetics Drug Sales Market Share by Application in 2019
Figure Global Hospital Sales Growth Rate (2015-2020)
Figure Global Household Sales Growth Rate (2015-2020)
Figure Global Antidiabetics Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Antidiabetics Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Antidiabetics Drug Price and Trend Forecast (2020-2025)
Table Global Antidiabetics Drug Sales (K Units) Forecast by Region (2020-2025)
Figure Global Antidiabetics Drug Production Market Share Forecast by Region (2020-2025)
Figure North America Antidiabetics Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Antidiabetics Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Antidiabetics Drug Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Antidiabetics Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Antidiabetics Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Antidiabetics Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Antidiabetics Drug Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Antidiabetics Drug Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table AstraZeneca Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of AstraZeneca
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Antidiabetics Drug Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Novo Nordisk Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of Novo Nordisk
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novo Nordisk Antidiabetics Drug Market Share (2018-2020)
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table Eli-Lilly Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of Eli-Lilly
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Eli-Lilly Antidiabetics Drug Market Share (2018-2020)
Table Eli-Lilly Main Business
Table Eli-Lilly Recent Development
Table Bayer Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of Bayer
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bayer Antidiabetics Drug Market Share (2018-2020)
Table Bayer Main Business
Table Bayer Recent Development
Table Novartis Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of Novartis
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis Antidiabetics Drug Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Boehringer Ingelheim Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of Boehringer Ingelheim
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Boehringer Ingelheim Antidiabetics Drug Market Share (2018-2020)
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Merck Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of Merck
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Merck Antidiabetics Drug Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Johnson & Johnson Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of Johnson & Johnson
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Johnson & Johnson Antidiabetics Drug Market Share (2018-2020)
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Sanofi Company Profile
Figure Antidiabetics Drug Product Picture and Specifications of Sanofi
Table Antidiabetics Drug Production, Price, Revenue and Gross Margin of 2018-2020
Figure Sanofi Antidiabetics Drug Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table of Appendix